Biomet U.K. Ltd.
8
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
50.0%
4 terminated/withdrawn out of 8 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Randomized Controlled Clinical Evaluation to Compare Vanguard Cruciate Retaining and AGC Total Condylar Knee Implants
Role: collaborator
Retrieval Study and Histological Examination Of A Hip Femoral Components With Hydroxyapatite Coatings
Role: collaborator
A Randomized Control Trial to Assess Early Clinical and Functional Outcome of the ROCC and LCS Total Knee Implant Designs
Role: collaborator
A Clinical Evaluation of Metal Ion Release From Metal-on-Metal Cementless Total Hip Arthroplasty
Role: collaborator
Retrospective Data Review of ReCap Total Hip Resurfacing
Role: collaborator
ReCap Total Hip Resurfacing Prospective Data Collection
Role: collaborator
Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures
Role: collaborator
Taperloc Versus Taplerloc Microplasty
Role: collaborator
All 8 trials loaded